Fintel reports that on October 14, 2024, Redburn Atlantic initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation.
Recent Mentions
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Sources
Mentions
Mentions of this stock across all news source scraped in the past 30 days
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Fintel
55%
Finnhub
15%
TipRanks
5%
Others
25%
•
•
•
•
•
•
•
•
Country
US
Industry
Health Care
Market Cap
Micro Cap
Num. Employees
65
IPO Date
Dec 3, 2014
Country
US
Industry
Health Care
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 65 full-time employees. The company went IPO on 2014-12-03. The firm is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The firm is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). The company is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
News Sentiment
Sentiment
Composite sentiment (positive vs. negative language) expressed across news sources mentioning this stock
Today
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Very Bullish
Related Stocks
Related Stocks
Stocks being mentioned with OCGN